APPLICATION
ANDA078710
TYPE
ANDA
ORIGINAL APPROVAL
2014-01-08
LATEST ACTION
2023-05-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
TELMISARTANPrescription
TELMISARTAN 40MG · TABLET · ORAL
TELMISARTANPrescription
TELMISARTAN 80MG · TABLET · ORAL
TELMISARTANPrescription
TELMISARTAN 20MG · TABLET · ORAL
Approval history
2023-05-01Manufacturing (CMC) · Supplement 7 · standardAP
2019-04-23Labeling · Supplement 4 · standardAP
2015-11-25Labeling · Supplement 2 · standardAP
2015-11-25Labeling · Supplement 1 · standardAP
2014-01-08OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.